Literature DB >> 33544383

Immunohistochemical Coexpression of MUC1 and MUC4 in Oral Leukoplakia and Oral Squamous Cell Carcinoma.

Renu Rathee1, Anju Devi2, Anjali Narwal2, Mala Kamboj2, Sunita Singh3.   

Abstract

MUC1 and MUC4 are two transmembranous proteins, which have been seen to express aberrantly in various human neoplasms and advocated as independent prognostic markers. Till now no extensive studies have been carried out on combined expression of MUC1 and MUC4 in oral leukoplakia and Oral squamous cell carcinoma. This study is an endeavour to evaluate Immunohistochemical coexpression of MUC1 and MUC4 in Oral Leukoplakia and Oral squamous cell carcinoma and furthr establish them as prognostic markers. Immunohistochemical analysis of MUC1 and MUC4 was done on 24 cases of Oral squamous cell carcinoma, 24 cases of leukoplakia and 12 normal oral mucosal tissues. Chi square test and one way ANOVA test were employed for statistical analysis. Normal oral mucosa and leukoplakia group showed higher frequency of negative immunoexpression compared to oral squamous cell carcinoma group. Furthur in Oral squamous cell carcinoma group, higher frequency of double positive coexpression in well and moderately differentiated oral squamous cell carcinoma and single positive coexpression in poorly differentiated oral squamous cell carcinoma was obtained. A definite rise of immunoexpression of MUC1 and MUC4 was observed from normal oral mucosa to leukoplakia to oral squamous cell carcinoma indicative of their contribution as diagnostic and prognostic markers.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Coexpression; Immunohistochemistry; Leukoplakia; Oral squamous cell carcinoma

Mesh:

Substances:

Year:  2021        PMID: 33544383      PMCID: PMC8384999          DOI: 10.1007/s12105-021-01291-y

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  22 in total

1.  MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.

Authors:  Shugo Tamada; Hiroaki Shibahara; Michiyo Higashi; Masamichi Goto; Surinder K Batra; Kohzoh Imai; Suguru Yonezawa
Journal:  Clin Cancer Res       Date:  2006-07-15       Impact factor: 12.531

Review 2.  Current potential and limitations of molecular diagnostic methods in head and neck cancer.

Authors:  Magdy E Mahfouz; Juan P Rodrigo; Robert P Takes; Mohamed N Elsheikh; Alessandra Rinaldo; Ruud H Brakenhoff; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06       Impact factor: 2.503

3.  MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.

Authors:  M Saitou; M Goto; M Horinouchi; S Tamada; K Nagata; T Hamada; M Osako; S Takao; S K Batra; T Aikou; K Imai; S Yonezawa
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

4.  Clinicopathologic features of oral squamous cell carcinoma: do they vary in different age groups?

Authors:  Matthias Troeltzsch; Thomas Knösel; Christina Eichinger; Florian Probst; Markus Troeltzsch; Timothy Woodlock; Gerson Mast; Michael Ehrenfeld; Sven Otto
Journal:  J Oral Maxillofac Surg       Date:  2014-01-23       Impact factor: 1.895

5.  Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors.

Authors:  Y Tashiro; S Yonezawa; Y S Kim; E Sato
Journal:  Hum Pathol       Date:  1994-04       Impact factor: 3.466

6.  Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma.

Authors:  K Yamashita; S Yonezawa; S Tanaka; H Shirahama; K Sakoda; K Imai; P X Xing; I F McKenzie; J Hilkens; Y S Kim
Journal:  Int J Cancer       Date:  1993-08-19       Impact factor: 7.396

7.  Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors.

Authors:  M Osako; S Yonezawa; B Siddiki; J Huang; J J Ho; Y S Kim; E Sato
Journal:  Cancer       Date:  1993-04-01       Impact factor: 6.860

8.  MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.

Authors:  Hiroaki Shibahara; Shugo Tamada; Michiyo Higashi; Masamichi Goto; Surinder K Batra; Michael A Hollingsworth; Kohzoh Imai; Suguru Yonezawa
Journal:  Hepatology       Date:  2004-01       Impact factor: 17.425

9.  Expression of mucin-1 in oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study.

Authors:  Arush Thakur; Jagdish V Tupkari; Tabita Joy; Prajwalit Prakash Kende; Pooja Siwach; Manisha S Ahire
Journal:  J Oral Maxillofac Pathol       Date:  2018 May-Aug

10.  MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.

Authors:  Yukihiro Tamura; Michiyo Higashi; Sho Kitamoto; Seiya Yokoyama; Masahiko Osako; Michiko Horinouchi; Takeshi Shimizu; Mineo Tabata; Surinder K Batra; Masamichi Goto; Suguru Yonezawa
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

View more
  1 in total

1.  Study on the mechanism of SALL4 down-regulation in promoting the invasion and migration of oral squamous cell carcinoma and influencing the survival and prognosis of patients.

Authors:  Jin Li; Bin Zhang; Rongchen Xu; Bingxin Wang; Wenjun Hao; Xiaoxiao Zhang
Journal:  Ann Transl Med       Date:  2022-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.